BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

IMVT upcoming catalysts

Immunovant Sciences GmbH: 0 upcoming industry Phase 2/3 trial readout(s) in the next 90 days (0 Phase 3), 0 upcoming FDA decision event(s), and in the last 12 months 5 readout(s) and 0 FDA event(s). Subscribe to IMVT (.ics).

Drugs: Batoclimab

Upcoming FDA decision events

DateEventStatusCompanyDrugSource
No upcoming PDUFA date or AdCom found.

Upcoming trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
No trials in this window.

FDA decision events, last 12 months

DateEventStatusCompanyDrugSource
No FDA decision events in this window.

Trial readouts, last 12 months

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-10 est.P2Immunovant Sciences GmbH IMVTNCT06980805 A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)Subacute Cutaneous Lupus Erythematosus; Chronic Cutaneous Lupus Erythematosusactive not recruiting56
2026-07-20P2Immunovant Sciences GmbH IMVTNCT05581199 To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDPChronic Inflammatory Demyelinating Polyneuropathyterminated94
2026-07-16P2Immunovant Sciences GmbH IMVTNCT07188844 An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Chronic Inflammatory Demyelinating Polyneuropathyterminated26
2026-04-02P3Immunovant Sciences GmbH IMVTNCT05517447 Extension Study to Assess Batoclimab in Participants With Thyroid Eye DiseaseThyroid Eye Diseaseterminated109
2026-02-03P3Immunovant Sciences GmbH IMVTNCT05524571 Study to Assess Batoclimab in Participants With Active Thyroid Eye DiseaseThyroid Eye Diseasecompleted86

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.